STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
STATEMENTS OF OPERATIONS
Grant income	$ 558,664	$ 462,754
Operating expenses:
Research and development	17,840,290	12,659,287
General and administrative	11,703,429	7,998,573
Total operating expenses	29,543,719	20,657,860
Operating loss	(28,985,055)	(20,195,106)
Other income	38,763	73,022
Loss on derivative instruments	(349,078)	(760,603)
Warrant inducement expense	(805,753)	0
Other non-operating gain	887,604	545,528
Interest expense, net	(1,041,725)	(1,797,481)
Net loss	(30,255,244)	(22,134,640)
Modification of warrants	(21,734)	0
Net loss available to common shareholders	$ (30,276,978)	$ (22,134,640)
Net loss per common share, basic and diluted	$ (0.82)	$ (0.71)
Weighted average common shares outstanding, basic and diluted	36,759,115	31,174,394